For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

AmerisourceBergen Corp. plans to settle a proposed class action by workers who say the pharmaceutical company’s retirement ...

02月07日 14:38 美国连锁药店沃尔格林联合博姿(Walgreens Boots Alliance)周四表示，已出售更多药品分销商Cencora的股份，套现约3亿美元。该公司目前在Cencora ...

How can pharmaceutical firms shore up their sustainability credentials at a time when the entire research landscape is turning on its head? A recent webinar from supply chain leaders World Courier and ...

We believe Cencora is well positioned to enjoy these dynamics and expect it to maintain a leading position over our forecast period. The company has partnerships with some of the biggest customers ...

Cencora Inc., a Conshohocken-based wholesale drug distributor, scrubbed a diversity, equity, and inclusion page from its ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...

Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...

Cencora is updating its outlook for fiscal year 2025. The Company does not provide forward-looking guidance on a GAAP basis as discussed below in Fiscal Year 2025 Expectations. Adjusted diluted ...

CONSHOHOCKEN, Pa., February 05, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year ...